Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NextCure, Inc. - Common Stock
(NQ:
NXTC
)
0.4747
+0.0247 (+5.49%)
Streaming Delayed Price
Updated: 12:20 PM EDT, Jun 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NextCure, Inc. - Common Stock
< Previous
1
2
Next >
Monday's session: top gainers and losers
June 16, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
June 16, 2025
Via
Benzinga
NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline
June 16, 2025
The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors.
Via
Stocktwits
Stay updated with the stocks that are on the move in today's pre-market session.
April 24, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
NXTC Stock Earnings: NextCure Beats EPS for Q4 2023
March 21, 2024
NXTC stock results show that NextCure beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates
November 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 09, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 19, 2025
Via
Benzinga
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
February 12, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 28, 2024
Via
Benzinga
NXTC Stock Earnings: NextCure Misses EPS for Q2 2024
August 01, 2024
NXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NXTC Stock Earnings: NextCure Misses EPS for Q1 2024
May 02, 2024
NXTC stock results show that NextCure missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
March 23, 2024
The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Friday's After-Market Session
March 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 14, 2023
Via
Benzinga
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
US Stocks Higher; Initial Jobless Claims Fall To 202,000
December 14, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
November 10, 2022
During Thursday's session, 97 companies made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 07, 2022
Gainers
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.